A new E. coli O157:H7 outbreak on the FDA's CORE Outbreak Table, and case count increases in other outbreak investigations are the changes in the latest update. There are seven active outbreak investigations on the table. Six of them are unsolved. The new E. coli O157:H7 outbreak in a not yet identified foods has sickened at least 25 people. The FDA has initiated traceback, but has not initiated a recall, inspected any facilities, or collected samples. There is no change in the Listeria monocytogenes outbreak that has sickened at least three people. The FDA has initiated traceback in this investigation. For the first Cyclospora outbreak that has sickened at least 41 people, that is an increase of six more illnesses. The FDA has initiated traceback, has started inspections, and … [Read more...]
New Listeria Monocytogenes Outbreak on FDA CORE Table
A new Listeria monocytogenes outbreak on the FDA CORE Table joins five other outbreaks, with case count increases in some. Five of the six outbreaks are unsolved. The new Listeria monocytogenes outbreak has sickened at least three people. FDA has initiated traceback in this outbreak investigation. For the Cyclospora outbreak that has sickened at least 35 people, FDA has initiated traceback. has started a site inspection, and has initiated sampling. This is an increase of 14 more patients since the last update. For the Salmonella Newport outbreak in a not yet identified food, four people are sick. FDA has initiated traceback and has started a site inspection. This is an increase of one more patient. For the second Cyclospora outbreak, 44 people are sick. The FDA has … [Read more...]
Diamond Shruumz illnesses Climb to 145 With 59 Hospitalized
Diamond Shruumz illnesses climb to 145 sick in 29 states with 59 hospitalized, according to the FDA. There are two potentially associated deaths as well. That is an increase of 15 more patients since the last update was issued on August 14, 2024. The case count by state is: Alabama (4), Arizona (11), California (3), Colorado (1), Florida (6), Georgia (23), Indiana (8), Iowa (5), Kansas (5), Kentucky (11), Maryland (2), Minnesota (3), Missouri (1), Montana (3), Nevada (2), New Jersey (2), New York (1), North Carolina (17), North Dakota (3), Oklahoma (1), Oregon (1), Pennsylvania (2), South Carolina (7), South Dakota (1), Tennessee (9), Texas (7), Virginia (3), Washington (2), and Wisconsin (1). The patient age range was not reported. Sample analysis is ongoing. A Sample Results … [Read more...]
Diamond Shruumz Outbreak Sickens 130 With 53 Hospitalized
The Diamond Shruumz outbreak sickens 130 in 29 states with 53 hospitalized, as of August 9, 2024, according to the FDA. That is an increase of 17 more patients and 11 more hospitalizations since the last update was published on August 7, 2024. There are two deaths that are potentially associated with these products. The case count by state is: Alabama (4), Arizona (7), California (3), Colorado (1), Florida (6), Georgia (23), Indiana (8), Iowa (3), Kansas (5), Kentucky (10), Maryland (2), Minnesota (3), Missouri (1), Montana (3), Nevada (1), New Jersey (2), New York (1), North Carolina (17), North Dakota (3), Oklahoma (1), Oregon (1), Pennsylvania (2), South Carolina (7), South Dakota (1), Tennessee (9), Texas (2), Virginia (1), Washington (2), and Wisconsin (1). The patient age … [Read more...]
Another Cyclospora Outbreak and New Salmonella Outbreak
Another cyclospora outbreak and a new Salmonella outbreak are listed on the FDA's CORE Outbreak Investigation Table, bringing the number of outbreaks under investigation to eight. Six of those eight outbreaks are unsolved. The newest outbreak is a cyclospora outbreak that has sickened at least two people. The FDA has initiated traceback but has not collected samples or started inspections. A new Salmonella Newport outbreak is on the table with two people sick. No product has been identified as the cause of the illnesses. The FDA has not initiated traceback, has not collected samples, or started inspections. The other two cyclospora outbreaks are unchanged. In the first outbreak, there are 26 patients, and in the second, there are 16 patients. In both of these outbreaks, the … [Read more...]
FDA Publishes Table of Compounds in Diamond Shruumz Products
The FDA has published a table of compounds found in Diamond Shruumz products. Tests of the company's cones and gummies have also been collected and are being analyzed. The case count remains at 113 sick in 28 states and 42 hospitalized, with two potential deaths. There is no information about case count by state, or the patient age range. The severe symptoms that patients have been experiencing include seizures, central nervous system depression (loss of consciousness, confusion, sleepiness), agitation, abnormal heart rates, hyper/hypotension, nausea, and vomiting. And it's troubling that some of these items may still be available for sale at smoke and vape shops, and at retailers that sell hemp-derived products. None of these items should be available for sale. If you see any at … [Read more...]
Diamond Shruumz Case Count Zooms to 113 Sick, 42 Hospitalized
The Diamond Shruumz case count zooms to 113 sick in 28 states and 42 hospitalized, according to the FDA. That is an increase of 35 patients since the last update was issued one day ago. Two people have died, but officials aren't sure if those deaths are associated with the consumption of these products. The numbers reflect a change to the case ascertainment and reporting process, which was implemented on August 2, 2024. No patient case count was provided in this update. The cause of the illnesses is still not known. The Centers for Disease Control and Prevention (CDC) states: "Products containing psychoactive compounds such as cannabis or mushroom extracts are increasing in availability. These "edibles" are often sold as gummy candies, chocolates, or other snack foods. They might … [Read more...]
Diamond Shruumz Outbreak Has Sickened 78 Patients
The Diamond Shruumz outbreak has sickened at least 78 patients, according to the FDA. That is an increase of four more patients since the last update was issued on July 23, 2024. Forty of those patients have been hospitalized. Sixty five of those patients have sought medical care. And there are two potentially associated deaths that are under investigation. The case count by state is: Alabama (4), Arizona (7), California (1), Colorado (2), Florida (1), Georgia (7), Indiana (6), Iowa (5), Kentucky (5), Maryland (1), Minnesota (2), Missouri (1), Montana (1), Nevada (1), New Jersey (2), New York (1), North Carolina (3), North Dakota (2), Ohio (2), Oklahoma (1), Oregon (1), Pennsylvania (2), South Carolina (5), South Dakota (1), Tennessee (5), Texas (1), Virginia (5), Washington (2), … [Read more...]
New Cyclospora Outbreaks on FDA CORE Outbreak Table
Two new Cyclospora outbreaks have been added to the FDA's CORE Outbreak Investigation Table. There are a total of six outbreaks on the table. Four of them have not been solved. A new outbreak of Cyclospora cayetanensis illnesses linked to a not yet identified product has been added to the table. There are 26 people sick. FDA has initiated traceback, but no samples have been collected and no inspection ordered. Another new outbreak of Cyclospora cayetanensis illnesses linked to a not yet identified product has been added to the table. Sixteen people are sick in that outbreak. FDA has initiated traceback but there has not been any inspection and no samples have been collected. There are typically some cyclospora outbreaks in the United States every summer. For the outbreak of … [Read more...]
More Illnesses Reported in Unsolved Outbreak by FDA
More illnesses reported in the unsolved Salmonella Imuru outbreak by FDA on that agency'c CORE Outbreak Table. Altogether there are five outbreaks on the table; three of them are not solved or linked to a specific product. The Salmonella Imuru outbreak case count has increased from 29 to 31 people sick. The FDA has conducted traceback, but there is no recall, no inspection of a facility, and no samples have been collected and analyzed. We do not know the patient age range, where the patients live, and whether or not anyone has been hospitalized. For the outbreak of Salmonella Typhimurium illnesses linked to a not yet identified product, the case count remains at 87. Again, the FDA has only started traceback, and not inspected any facilities, has not collected samples, and has … [Read more...]
